Top compounds associated with response to PDCD1LG2


Feature Type Standardized
Nominal ANOVA
mRNA GSK2126458 GDSC1000 pan-cancer AAC -0.091 0.004
mRNA GSK-J4 CTRPv2 pan-cancer AAC -0.38 0.004
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.004
mRNA BMS-754807 GDSC1000 pan-cancer AAC -0.095 0.005
mRNA AR-42 GDSC1000 pan-cancer AAC -0.086 0.005
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.097 0.005
mRNA paclitaxel CTRPv2 pan-cancer AAC -0.094 0.005
mRNA Cytarabine CTRPv2 pan-cancer AAC -0.08 0.006
mRNA GW843682X CTRPv2 pan-cancer AAC -0.098 0.006
mRNA Vorinostat gCSI pan-cancer AAC -0.14 0.006
Download CSV